Inspire Pharmaceuticals | Merck | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
General Nutrition Centers Inc. | Harbin Pharmaceutical Group | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
Inspire Pharmaceuticals Inc. | Merck | off-label or unapproved promotion of medical products | 2015 | USAO | $5,900,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
UCB Holdings, Inc. | UCB | benefit plan administrator violation | 2017 | private lawsuit-federal | $5,500,000 |
Warner Chilcott Holdings | AbbVie | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2013 | DOJ_CIVIL | $5,475,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Merck & Co. Inc. | Merck | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2006 | PA-ENV | $5,033,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
Synthes USA | Johnson & Johnson | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,860,779 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,800,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Johnson and Johnson | Johnson & Johnson | consumer protection violation | 2009 | WV-AG | $4,475,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Warrick Pharmaceuticals Inc. | Merck | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
GlaxoSmithKline | GSK plc | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
Merck and Company, Inc. | Merck | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Forest Laboratories, Inc. | AbbVie | employment discrimination | 2018 | private lawsuit-federal | $4,000,000 |
Actavis | AbbVie | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Medicis Pharmaceutical Corporation | Bausch Health | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2010 | DOJ_CIVIL | $3,725,000 |
GlaxoSmithKline | GSK plc | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | air pollution violation | 2008 | EPA | $3,650,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | USAO | $3,500,000 |
Allergan Inc. | AbbVie | False Claims Act and related | 2018 | USAO | $3,500,000 |
Amgen and Immunex | Amgen | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
GlaxoSmithKline | GSK plc | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Ranbaxy Laboratories Ltd. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
Pfizer, Inc. | Pfizer | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline LLC | GSK plc | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $3,202,500 |
Abiomed, Inc. | Johnson & Johnson | False Claims Act and related | 2018 | USAO | $3,100,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000 |
Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $3,000,000 |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | HHS civil monetary penalties | 2007 | HHSOIG | $2,950,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |